Supreme Court calls Rs 27,000 cancer drug price a daylight robbery
Published · Updated
AI-generated summary of the coverage listed below: The Supreme Court described the Rs 27,000 MRP on a cancer drug sold to retailers at Rs 2,700 as a broad daylight dacoity. The court criticized the pricing as an unfair practice.
Covered by 4 outlets across the spectrum: 25% left, 25% center, 50% right.
Who is covering this story
- Left-leaning (1): The Hindu
- Center (1): The New Indian Express
- Right-leaning (2): Times of India, India Today
Sources
- Exorbitant pricing of drugs is ‘extortion': Supreme Court — Times of India (right-leaning)
- Rs 2,700 cancer drug selling for Rs 27,000: Supreme Court calls it daylight robbery — India Today (right-leaning)
- SC calls Rs 27,000 MRP on cancer drug sold to retailers at Rs 2,700 ‘broad daylight dacoity’ — The New Indian Express (center)
- ‘Broad daylight dacoity’, says Supreme Court on overpricing of essential cancer drugs — The Hindu (left-leaning)